High1/2 relationships sourcedProfile verified Aug 29, 2026
OverviewIndicatorsMore SignalsSourcesM&A fitRelationship mapStoryMilestones

30-Second Executive Brief

Executive Assessment

Cardinal Health functions as an established institution within Healthcare & Life Sciences, backed by 55% sourcing coverage, with accelerating strategic relevance.

  • Maintains 2 mapped relationships across the graph
  • 55% sourcing coverage across sourced relationships
  • Tracked as established institution within the Healthcare & Life Sciences category

Executive Snapshot

Strategic Role
Established Institution
Sourcing Coverage
55%
View Methodology →

Computed live from this entity's own relationships and evidence: how many relationships carry at least one linked citation, weighted with citation recency and source type — independent of Strategic Importance, and not a prediction. Not a hand-typed number; recalculated on every read.

Ecosystem Influence
High
Strategic Momentum
Accelerating

Coverage

Mapped Relationships
2
Technology Domains
3

Strategic Implications

  • Central node connecting multiple strategic ecosystems
  • Directly influences technology and capital flows
  • Material relevance to downstream dependency mapping

Top Opportunities

FY2027 guidance of 13-15% non-GAAP EPS growth reflects continued confidence in distribution volume and operational efficiency gains.

Top Risks

Thin-margin pharmaceutical distribution business requires continued volume growth and operational efficiency to sustain double-digit earnings growth.

Critical Dependencies

Continue to Dependency Graph ↓

Major US pharmaceutical and medical products distributor; reported fiscal year 2026 (ended June 2026) revenues of $254.2 billion (up 14% year-over-year) with non-GAAP diluted EPS up 37% to $11.26, and guided fiscal year 2027 non-GAAP diluted EPS of $12.40-12.60, representing 13-15% growth.

⚡

Leading Indicators

Hiring and patent filing trends — the underlying numbers Momentum is computed from. Insider filing activity is tracked separately under Sources below.

Steadyinsider filing activity unchanged since last check
⚡

Additional Intelligence Signals

Patent citation lineage, earnings-call mentions, and federal contract disclosures — automatically collected, not yet visible anywhere else on the site.

Federal contract disclosures

Department of Defense — $11,049,212: 4570333097!OCP, JFAK COMPLETE, NSN 6545-01-632-0167

USAspending.gov · Dec 19, 2025

Department of Veterans Affairs — $3,004,754: RADIOPHARMACEUTICALS

USAspending.gov · Oct 1, 2025

Department of Defense — $2,818,257: 8510084616!SUPPLYLINE MASTER AGREEMENT

USAspending.gov · Sep 20, 2023

Department of Veterans Affairs — $2,717,102: RADIOPHARMACEUTICALS NF/SG VHS FY25 10-01-2024 TO 09-30-2025

USAspending.gov · Oct 1, 2024

Department of Veterans Affairs — $2,715,757: RADIOPHARMACEUTICALS

USAspending.gov · Oct 1, 2022

⚡

Sources

Every claim traced to a primary source — evidence, recent activity, and insider filing behavior, all in one place.

Evidence

1 source

  • RTTNews — Cardinal Health Delivers Double-Digit FY2026 Earnings Growth; Sets Strong FY2027 Outlooknews

Latest Activity

Insider Filing Activity

23Form 4 filings, trailing 90 days0 since last week's snapshot

Counts filing frequency only — transaction direction/size wasn't parseable from the sampled filings · sourced from SEC EDGAR · as of Sep 7, 2026

Correlated Activity

Both Cardinal Health and Cencora — which depends on it — are showing accelerating Activity at the same time (1 recorded change for Cencora in the last 90 days).

Timing correlation only — not evidence of a causal link

⚡

Acquisition & Investment Fit

AI-reasoned, generated only from entities already in InsightNodes's own graph — a hypothetical strategic-fit exercise, not real M&A intelligence or a signal that any deal is planned or in progress.

⚡

Relationship Map

The relationships surrounding Cardinal Health — ownership, dependencies, regulation, technology and market context. Click any node to make it the new center, 2 levels deep.

2 levels3 levels 🔒5 levels 🔒

Connection type

Sign in free to click a node and explore →

Click any node to make it the new center. Scroll to zoom, drag to pan.

⚡

The Story So Far (last 6 months)

Aug 2026: FY2026 revenue rises 14% to $254.2 billion; sets strong FY2027 outlook→Aug 2026: Cardinal Health Delivers Double-Digit FY2026 Earnings Growth; Sets Strong FY2027 Outlook

Auto-generated from this entity's dated milestones, relationship updates, and sourced evidence — not AI-written, just sorted.

⚡

Cardinal Health's Timeline

A sourced, dated history of Cardinal Health's key moments — founding to present.

  1. Aug 2026 · FY2026 revenue rises 14% to $254.2 billion; sets strong FY2027 outlook

    Cardinal Health reported FY2026 revenues of $254.2 billion, up 14% year-over-year, with non-GAAP operating earnings up 30% to $3.624 billion and non-GAAP diluted EPS up 37% to $11.26; the company guided FY2027 non-GAAP diluted EPS of $12.40-12.60, representing 13-15% growth.